Â鶹´«Ã½

    Advertisement
    In the last 7 days
    Talking Points Memo09:52
    Centers for Disease Control and Prevention22:14 23-Dec-24
    Belga News Agency05:39 24-Dec-24
    The New Times04:31 24-Dec-24
    Nature.com00:07 24-Dec-24

    About our Mpox news

    Latest news on mpox (monkeypox), providing comprehensive coverage of outbreaks, prevention measures, vaccination efforts, and global health responses to this viral disease.

    Mpox, formerly known as monkeypox, is a viral infection caused by Orthopoxvirus monkeypox. The disease has gained global attention since the unprecedented 2022-2023 outbreak, which saw over 93,000 cases reported worldwide. Mpox typically causes a rash, fever, and swollen lymph nodes, with symptoms lasting 2-4 weeks.

    As of 19 August 2024, health authorities are grappling with a new outbreak of the more virulent clade I mpox in Central Africa. The World Health Organization (WHO) declared this outbreak a Public Health Emergency of International Concern on 14 August, citing its rapid spread and high case fatality rate of around 5%. The outbreak has now reached several African countries, including the Democratic Republic of Congo, Republic of Congo, Uganda, Kenya, Rwanda, and Burundi. Alarmingly, the first case outside Africa was reported in Sweden on 15 August, raising concerns about potential global spread.

    The current outbreak disproportionately affects children, who account for an estimated 64% of cases and 85% of fatalities. This has prompted urgent calls for increased vaccination efforts and public health measures. Meanwhile, communities in affected areas are mobilising to raise awareness and support those impacted by the disease.

    Mpox has a complex history, with the first human case identified in 1970 in the Democratic Republic of Congo. Since then, sporadic outbreaks have occurred in Central and West Africa. The 2022-2023 global outbreak marked a significant shift, as it was the first time widespread community transmission occurred outside Africa. This led to increased research efforts and the development of new prevention and treatment strategies.

    As the situation continues to evolve, staying informed about mpox developments is crucial. Our Â鶹´«Ã½ feed provides up-to-date, comprehensive coverage from reliable sources, including the WHO, national health agencies, and leading research institutions. Whether you're a healthcare professional, policymaker, or concerned citizen, our feed ensures you have the latest information on this important global health issue.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.